Basic information
Biomarker: VEGF
Histology type: endometrial carcinoma
Cohort characteristics
Country: Romania
Region: Arad
Followed up time :
Subgroup 1 name : negative
Subgroup 1 number: 6
Subgroup 2 name: positive
Subgroup 2 number: 48
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
64 | EC | 54 | Normal histologic proliferative endometrium | 10 |
Sample information
Conclusion: VEGF is important indicators of a poor prognosis in patients with endometrial carcinoma.
Sample type : tissue
Sample method: immunohistochemistry
Expression pattern : positive
Expression elevation: ▪ Intensity of staining: – 0=negative response; – 1=weak intensity; – 2=moderate intensity; – 3=strong intensity; ▪ Percentage of positive cells: – 0=negative (0% immunopositive cells); – 1=positive immunoreaction in <25% of tumor cells cytoplasm; – 2= positive immunoreaction in 26–50% of tumor cells cytoplasm; – 3= positive immunoreaction in >50% of tumor cells cytoplasm. Final score was obtained by summing the two parameters, with the following interpretation for the immunohistochemical reaction: ▪ a negative immunoreaction for a score between 0 and 2; ▪ a slightly positive immunoreaction for a score between 3 and 4; ▪ a strongly positive immunoreaction for a score between 5 and 6.
Disease information
Statictics: cutoff<60;cutoff>60
Cohort age: 57; 38 - 81
Subgroup 1 age: 5;1
Subgroup 2 age: 30;18
Related information
Funtion Uniprot: Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145. Isoform VEGF165B binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth. Binding to NRP1 receptor initiates a signaling pathway needed for motor neuron axon guidance and cell body migration, including for the caudal migration of facial motor neurons from rhombomere 4 to rhombomere 6 during embryonic development (By similarity). Also binds the DEAR/FBXW7-AS1 receptor (PubMed:17446437).
UniProt ID: P15692
UniProt Link: https://www.uniprot.org/uniprotkb/P15692/entry
Biological function from UniProt: #Angiogenesis #Differentiation
Molecular function from UniProt:
Tissue specificity from UniProt: Isoform VEGF189, isoform VEGF165 and isoform VEGF121 are widely expressed. Isoform VEGF206 and isoform VEGF145 are not widely expressed. A higher level expression seen in pituitary tumors as compared to the pituitary gland.
Subcellular UniProt: #Secreted
Alternative name from UniProt:
Recommended name: Vascular endothelial growth factor A
Gene name from HGNC: Vascular endothelial growth factor A
HPA class: Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Human disease related genes Plasma proteins RAS pathway related proteins
AlphaFold DB: P15692
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/P15692
Induction: By hypoxia. Regulated by growth factors, cytokines, gonadotropins, nitric oxide, hypoglycemia and oncogenic mutations.
HPA link: https://www.proteinatlas.org/ENSG00000112715-VEGFA
Tissue specificity RNA from HPA: Low tissue specificity
Tissue expression from HPA: Ubiquitous cytoplasmic expression.
Single cell type specificity Cell type enhanced (Alveolar cells type 1, Muller glia cells)
Immune cell specificity: Not detected in immune cells
Cancer prognostic summary HPA Prognostic marker in renal cancer (unfavorable), liver cancer (unfavorable), endometrial cancer (unfavorable), urothelial cancer (favorable) and cervical cancer (unfavorable)
Pathology link: https://www.proteinatlas.org/ENSG00000112715-VEGFA/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000112715-VEGFA/pathology/endometrial+cancer
Phenotype ID: 603933
Disease: Microvascular complications of diabetes 1 (MVCD1)
Note1: Disease susceptibility is associated with variants affecting the gene represented in this entry
OMIM: 192240
OMIM link1: https://www.omim.org/entry/603933
OMIM link2: https://www.omim.org/entry/192240
HGNC ID: HGNC:12680
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:12680